All blog posts
Total 14 results for
Showing 12 out of 14 results
16 December 2019
RATIFICATION OF THE UPC AGREEMENT IN SIGHT? GERMAN CONSTITUTIONAL DECISION LIKELY EARLY IN 2020
04 December 2019
European pharma patent law update
12 November 2019
Harnessing the power of diversity in IP
22 October 2019
Patent and Pharma Update, October 2019
03 October 2019
Open Innovation: Getting the IP right in collaborations
18 September 2019
CJEU refuses UK High Court's request for preliminary ruling on SPC applications based on third-party MAs, on account of referred question being "hypothetical" (C-239/19 Eli Lilly v Genentech)
11 September 2019
Updated HSF Legal Guide to Brexit published (including IP and Pharma sections)
11 July 2019
Open Innovation: Collaborate to Innovate
10 June 2019
New German Trade Secrets Act Enacted
08 May 2019
Data Assets - Protecting and Driving Value in a Digital Age
05 April 2019
Patent and Pharma Update - April 2019
25 March 2019
The Court of Justice of the European Union holds that Supplementary Protection Certificates cannot be obtained for new formulations of previously approved active ingredients in Abraxis (Case C-443/17)
Showing 12 out of 14 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Kewei, Mainland China and Shanghai
Alexandra Neri
Partner, Paris, Korea Group and Africa Group
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London